Dr Reddy’s Laboratories Ltd ADR
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $83,586,000 | $80,162,000 | $76,727,000 | $76,727,000 |
Gross Profit | 49,052,000 | 47,769,000 | 46,344,000 | 46,344,000 |
EBITDA | 24,279,000 | 23,899,000 | 21,757,000 | |
EBIT | 19,560,000 | 19,924,000 | 17,947,000 | |
Net Income | 14,133,000 | 12,553,000 | 13,920,000 | 13,920,000 |
Net Change In Cash | 83,586,000 | 80,162,000 | 76,727,000 | 76,727,000 |
Free Cash Flow | -2,199,000 | 1,407,000 | 2,072,000 | 2,072,000 |
Cash | 12,289,000 | 11,330,000 | 4,913,000 | 4,913,000 |
Basic Shares | 834,297 | 834,114 | 832,726 | 833,932 |
Annual Financials
| Values in thousands | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
|---|---|---|---|---|
Revenue | $279,164,000 | $245,879,000 | $214,391,000 | $189,722,000 |
Gross Profit | 163,607,000 | 202,972,000 | 113,840,000 | 103,077,000 |
EBITDA | 88,422,000 | 74,431,000 | 47,743,000 | 45,706,000 |
EBIT | 73,581,000 | 61,795,000 | 35,919,000 | 32,910,000 |
Net Income | 55,684,000 | 45,067,000 | 23,568,000 | 17,238,000 |
Net Change In Cash | 279,164,000 | 245,879,000 | 214,391,000 | 189,722,000 |
Free Cash Flow | 17,998,000 | 40,009,000 | 9,059,000 | 23,142,000 |
Cash | 7,107,000 | 5,779,000 | 14,852,000 | 14,829,000 |
Basic Shares | 833,537 | 831,912 | 831,693 | 831,580 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | $16.93 |
2024-09-30 | $0.18 |
2024-06-30 | $83.46 |
2024-03-31 | $78.35 |
